Literature DB >> 18208896

Cross-cultural adaptation and validation of the 'Multiple Sclerosis Quality of Life Instrument' in Hungarian.

J Füvesi1, K Bencsik, K Benedek, K Mátyás, E Mészáros, C Rajda, E Losonczi, Zs Fricska-Nagy, L Vécsei.   

Abstract

Health-related quality of life measurements are gaining more importance in the study and clinical practice of multiple sclerosis. The aim of our study was the adaptation of the Multiple Sclerosis Quality of Life Instrument (MSQOL-54) in Hungarian. The study was carried out at the Department of Neurology, University of Szeged and two other multiple sclerosis centers. The Hungarian translation of the questionnaire was given to patients at the outpatient units of the neurology departments. The EDSS score of the patients were determined and data concerning the onset and the clinical form of the disease was collected. Altogether 438 patients filled out the questionnaire. We enrolled patients with all clinical forms of the disease. Cronbach's alpha coefficients were over 0.8 in case of all scales except ;Rolelimitations - emotional' (0.794), indicating a good internal consistency reliability for group comparisons. The instrument was able to distinguish between known clinical group differences. The Hungarian version of the MSQOL-54 instrument shows good psychometric properties similar to the original questionnaire.

Entities:  

Mesh:

Year:  2008        PMID: 18208896     DOI: 10.1177/1352458507082724

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  9 in total

1.  Assessing measurement invariance of MSQOL-54 across Italian and English versions.

Authors:  Andrea Giordano; Silvia Testa; Marta Bassi; Sabina Cilia; Antonio Bertolotto; Maria Esmeralda Quartuccio; Erika Pietrolongo; Monica Falautano; Monica Grobberio; Claudia Niccolai; Beatrice Allegri; Rosa Gemma Viterbo; Paolo Confalonieri; Ambra Mara Giovannetti; Eleonora Cocco; Maria Grazia Grasso; Alessandra Lugaresi; Elisa Ferriani; Ugo Nocentini; Mauro Zaffaroni; Alysha De Livera; George Jelinek; Alessandra Solari; Rosalba Rosato
Journal:  Qual Life Res       Date:  2019-11-09       Impact factor: 4.147

2.  Real-World Evidence for Favourable Quality-of-Life Outcomes in Hungarian Patients with Relapsing-Remitting Multiple Sclerosis Treated for Two Years with Oral Teriflunomide: Results of the Teri-REAL Study.

Authors:  Krisztina Bencsik; Enikő Dobos; Zita Jobbágy; Adrienne Jóri Birkás; Krisztina Kovács; Mária Sátori; Gyula Lencsés; Gabor Bartok; Erika Losonczi; László Vécsei
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-13

3.  Measuring health-related quality of life in Hungarian children attending a cardiology clinic with the Pediatric Quality of Life Inventory.

Authors:  Andrea Berkes; James W Varni; István Pataki; László Kardos; Csilla Kemény; Gábor Mogyorósy
Journal:  Eur J Pediatr       Date:  2009-09-19       Impact factor: 3.183

4.  Validation of the Disease-specific Questionnaire MSQoL-54 in Bosnia and Herzegovina Multiple Sclerosis Patients Sample.

Authors:  Tarik Catic; Josip Culig; Enra Suljic; Admir Masic; Refet Gojak
Journal:  Med Arch       Date:  2017-04

5.  Validation of The Slovenian Version of Multiple Sclerosis Quality of Life (MSQOL-54) Instrument.

Authors:  Biljana Stern; Tanja Hojs Fabjan; Ksenija Rener-Sitar; Lijana Zaletel-Kragelj
Journal:  Zdr Varst       Date:  2017-10-09

6.  Contributing factors to health-related quality of life in multiple sclerosis.

Authors:  Tamás Biernacki; Dániel Sandi; Zsigmond Tamás Kincses; Judit Füvesi; Csilla Rózsa; Klotild Mátyás; László Vécsei; Krisztina Bencsik
Journal:  Brain Behav       Date:  2019-11-11       Impact factor: 2.708

7.  The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary.

Authors:  Tamás Biernacki; Dániel Sandi; Judit Füvesi; Zsanett Fricska-Nagy; Tamás Zsigmond Kincses; Péter Ács; Csilla Rózsa; Enikő Dobos; Botond Cseh; László Horváth; Zsuzsanna Nagy; Attila Csányi; Krisztina Kovács; Tünde Csépány; László Vécsei; Krisztina Bencsik
Journal:  PLoS One       Date:  2022-04-22       Impact factor: 3.752

8.  Measuring the quality of life in patients with multiple sclerosis in clinical practice: a necessary challenge.

Authors:  Karine Baumstarck; Laurent Boyer; Mohamed Boucekine; Pierre Michel; Jean Pelletier; Pascal Auquier
Journal:  Mult Scler Int       Date:  2013-02-28

9.  Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory.

Authors:  Rosalba Rosato; Silvia Testa; Antonio Bertolotto; Paolo Confalonieri; Francesco Patti; Alessandra Lugaresi; Maria Grazia Grasso; Anna Toscano; Andrea Giordano; Alessandra Solari
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.